Table 1.

a: Differentially Expressed MicroRNAs for all patients (Ulcerative colitis and Crohn’s disease)
Dysregulated microRNA	p-value*	Fold Change Non-neoplasia to Dysplasia	Fold Change Non-neoplasia to Cancer	Fold Change Dysplasia to Cancer
miR-193b	0.0016	−1.29	−1.98	−1.54
miR-373	0.0009	−1.28	−2.00	−1.56
let-7e	0.0001	−1.16	−1.87	−1.61
miR-15b	0.0012	−1.17	−1.89	−1.62
miR-372	0.0018	−1.20	−1.96	−1.63

b: Differentially Expressed MicroRNAs (DEMs) for Crohn’s disease patients
Dysregulated microRNA	p-value*	Fold Change Non-neoplasia to Dysplasia	Fold Change Non-neoplasia to Cancer	Fold Change Dysplasia to Cancer
miR-122	0.0009	+2.05	−1.68	−3.85
miR-181a	0.0011	+2.25	−1.69	−3.80
miR-146b-5p	0.0031	+2.00	−1.65	−3.31
let-7e	0.0003	+2.29	−1.52	−3.49
miR-17	0.0052	+2.22	−1.61	−3.56
miR-143	0.0024	+2.03	−1.74	−3.53

^*Global p-value calculated for any difference in miRNA dysregulation in the cohort. This p-value was calculated at a False Discovery Rate (FDR) <10%